Effect of royal Jelly and Omega-3 in multiple sclerosis

Clinical study of the Royal jelly effect on fatigue and quality of life in patients with multiple sclerosis in compare with Omega-3

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111105008013N3

Enrollment

Registered

2018-09-29

Start date

2018-05-21

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Multiple sclerosis. Condition 2: Neurasthenia. Multiple sclerosis Neurasthenia

Interventions

Intervention 1: Intervention group: Interferon (main treatment) with Omega-3 capsules (1 g daily) for one month. Intervention 2: Intervention group: Intervention group: Interferon (main treatment) wit

Eligibility

Sex/Gender

All

Age

15 Years to 66 Years

Inclusion criteria

Inclusion criteria: Multiple sclerosis patients have fatigue

Exclusion criteria

Exclusion criteria: other neurological disease Diseases like diabetes and autoimmune diseases new attack in the last month Emergence of drug side effects New disease attack Pregnancy

Design outcomes

Primary

Measure	Time frame
Fatigue. Timepoint: Start intervention and a month later. Method of measurement: MFIS questionnaire.;Quality of Life. Timepoint: Start intervention and a month later. Method of measurement: MSQL-54 questionnaire.;Blood parameters. Timepoint: MSQL-54 questionnaire. Method of measurement: Blood laboratory analysis.	—

Secondary

Measure	Time frame
Side effects. Timepoint: One month after the intervention began. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Siahpoosh

Ahvaz University of Medical Sciences

siahpoosh-a@ajums.ac.ir+98 61 3334 2197

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026